Uploaded September 2022 | Updated September 2026, 3 days ago
Discover the cutting-edge advancements in diabetes research as Prof. Maike Sander, winner of the 16th Albert Renold Lecture at EASD 2022, discusses the reconstruction of beta cells from stem cells. Despite battling COVID-19, Dr. Sander shared her insights on the progress, challenges, and translational potential of stem cell-derived beta cells for treating diabetes.
Learn how this groundbreaking work is shaping the future of therapeutic applications and human disease modelling, bridging the gap between research and patient care. As we celebrate a century since the discovery of insulin, Dr. Sander highlights the untapped potential of new genomic technologies and high-throughput approaches in advancing diabetes treatment and research.
Stay inspired by the innovative strides being made in the fight against diabetes!
#easd2022 #diabetes #betacells #stemcells #AlbertRenoldLecture #EASD2022 #Insulin100Years
Discover the cutting-edge advancements in diabetes research as Prof. Maike Sander, winner of the 16th Albert Renold Lecture at EASD 2022, discusses the reconstruction of beta cells from stem cells. Despite battling COVID-19, Dr. Sander shared her insights on the progress, challenges, and translational potential of stem cell-derived beta cells for treating diabetes.
Learn how this groundbreaking work is shaping the future of therapeutic applications and human disease modelling, bridging the gap between research and patient care. As we celebrate a century since the discovery of insulin, Dr. Sander highlights the untapped potential of new genomic technologies and high-throughput approaches in advancing diabetes treatment and research.
Stay inspired by the innovative strides being made in the fight against diabetes!
#easd2022 #diabetes #betacells #stemcells #AlbertRenoldLecture #EASD2022 #Insulin100Years










